Gena Wang

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Gena Wang works at BARCLAYS and is focused on the Healthcare sector with 495 price targets and ratings documented since 2015 spanning on 35 stocks. Previously, Gena Wang worked at JEFFERIES. Analyst's average stock valuation to be materialised ratio is 62.49% with an average time for price targets to be met of 172.35 days.

Most recent stock forecast was given on SGEN, Seattle Genetics, Inc at 14-Mar-2023.

Gena Wang best performing recommendations are on SGTX (SIGILON THERAPEUTICS INC).
The best stock recommendation documented was for SGTX (SIGILON THERAPEUTICS INC) at 12/29/2020. The price target of $48 was fulfilled within 2 days with a profit of $10.6 (28.34%) receiving and performance score of 141.71.

Average potential price target upside

Currently, out of the existing stock ratings of Gena Wang - 19678 which are a Buy (67.25%), 6083 which are a Hold (20.79%), 3501 which are a Sell (11.96%)

ALNY ARCT AVRO BCRX BEAM BLUE CLVS CRSP DBTX EDIT IONS KOD LOGC NTLA PBYI PGNX PTCT RARE RGNX SGEN SGMO SGTX SLDB SRPT VIR BMRN ONCE VRTX CLLS MGTX MRNA ORTX ZYME IDRA LEGN

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

415

$225.02 (118.44%)

415

24 days ago

1/5 (20%)

$132.63 (72.68%)

664

Buy

240

$50.02 (26.33%)

240

1 months 3 days ago

9/10 (90%)

$24.7 (15.49%)

199

Buy

249

$59.02 (31.07%)

256

1 months 3 days ago

12/14 (85.71%)

$31.46 (20.49%)

139

Buy

304

$114.02 (60.02%)

304

1 months 3 days ago

6/8 (75%)

$40.31 (32.66%)

421

Buy

250

$60.02 (31.59%)

250

1 months 3 days ago

9/11 (81.82%)

$43.49 (48.18%)

396

Show more analysts
ALNY ARCT AVRO BCRX BEAM BLUE CLVS CRSP DBTX EDIT IONS KOD LOGC NTLA PBYI PGNX PTCT RARE RGNX SGEN SGMO SGTX SLDB SRPT VIR BMRN ONCE VRTX CLLS MGTX MRNA ORTX ZYME IDRA LEGN